Preventing Respiratory Syncytial Virus
in High Risk Populations
 A continuing medical education activity sponsored by NAMCP and AAMCN
This activity was held live at the 2008 Fall Managed Care Forum.

This activity is valid from January 5, 2009 to December 31, 2009
 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from MedImunne, Inc.
PLEASE CLICK HERE TO VIEW PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit to keads@namcp.org.  A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Summary
Respiratory syncytial virus (RSV) continues to be a major cause of infant morbidity, resulting in rising hospital admission rates and costs. Infection with this virus early in life can have long-term consequences such as asthma. Children with certain risk factors are particularly vulnerable to infection with RSV and should receive prophylaxis during the RSV season. Emerging data indicates that appropriate prophylaxis in high risk children reduces long-term respiratory morbidity.

Objectives

  • Review the clinical epidemiology of prematurity

  • Review the public health impact of prematurity

  • Understand Respiratory syncytial virus (RSV) as an example of a surmountable barrier to optimizing preterm infant outcomes
Faculty: Michael Forbes, MD, Pediatric & Adolescent Intensivist, Director, Clinical Research and Outcomes Analysis, Pediatric Critical Care Medicine, Akron Children’s Hospital.
   

Disclosure:

 Dr. Forbes has disclosed the following relationships:
Research Grant Funds Advisory Boards: MedImmune, Inc.
  The NAMCP planning committee has no real or perceived financial relationships to disclose.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM. Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA) VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1.0 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

  

This activity is supported by an educational grant from MedImmune, Inc.